Boundless Bio EBITDA Margin 1970-1969 | BOLD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Boundless Bio (BOLD) over the last 10 years. The current EBITDA margin for Boundless Bio as of December 31, 1969 is .
| Boundless Bio EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Boundless Bio Inc. is a clinical stage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers. Boundless Bio Inc. is based in SAN DIEGO.
|
